| Unique ID issued by UMIN | UMIN000055889 |
|---|---|
| Receipt number | R000063871 |
| Scientific Title | A study to determine the effective timing and intensity of interventions to reduce the progression from impaired glucose tolerance to type 2 diabetes mellitus |
| Date of disclosure of the study information | 2024/10/21 |
| Last modified on | 2024/10/20 21:21:13 |
A study to determine the effective timing and intensity of interventions to reduce the progression from impaired glucose tolerance to type 2 diabetes mellitus
A study to determine the effective timing and intensity of interventions to reduce the progression from impaired glucose tolerance to type 2 diabetes mellitus
A study to determine the effective timing and intensity of interventions to reduce the progression from impaired glucose tolerance to type 2 diabetes mellitus
Study of timing and intensity of intervention for glucose impaired tolerance
| Japan |
Impaired Glucose Tolerance (IGT)
| Medicine in general | Cardiology | Endocrinology and Metabolism |
Others
NO
To determine the timing and intensity of interventions for persons with impaired glucose tolerance
Efficacy
Hazard ratios for the development of type 2 diabetes mellitus
Others,meta-analysis etc
| 19 | years-old | <= |
| Not applicable |
Male and Female
1. RCT trials investigating the effects of preventing the progression of type 2 diabetes mellitus
2. English language articles
3. Full-text available
1. Trials where inhibition of progression of type 2 diabetes mellitus has not been studied
2. Trials for which 2-hour post-load blood glucose values are not available
3. Trials not including IGT (subjects with normal glucose, impaired fasting glucose (IFG) only, diabetes mellitus, other diseases (e.g., nephropathy))
4. Adults (19 years of age or older)
5. Not pregnant
6. Trials examining drugs other than diabetes mellitus medications
7. Trials with a follow-up period of less than 6 months
8. Trials for which the number of events for the outcome is not available
9. Not an Article
| 1st name | Kotoba |
| Middle name | |
| Last name | Okuyama |
Toho University
Department of Medical Statistics, Graduate School of Medicine
143-8540
5-21-16 Omori-nishi, Ota-ku, Tokyo 143-8540, Japan
03-3762-4151
md19013o@st.toho-u.jp
| 1st name | Kotoba |
| Middle name | |
| Last name | Okuyama |
Toho University
Department of Medical Statistics, Graduate School of Medicine
143-8540
5-21-16 Omori-nishi, Ota-ku, Tokyo 143-8540, Japan
03-3762-4151
md19013o@st.toho-u.jp
Toho University
None
Self funding
NA
NA
NA
NA
NO
| 2024 | Year | 10 | Month | 21 | Day |
Unpublished
Preinitiation
| 2024 | Year | 10 | Month | 21 | Day |
| 2024 | Year | 10 | Month | 21 | Day |
| 2024 | Year | 12 | Month | 31 | Day |
Information to be obtained from literature:
1. Follow-up period (mean or median)
2. Baseline 2-hour post-glucose glucose (group combined mean)
3. Mean change from baseline to the most recent post-intervention 2-hour post-glucose glucose level for each group
4. Baseline fasting blood glucose (group combined mean)
5. Mean change from baseline to most recent post-intervention fasting plasma glucose in each group
6. Baseline HbA1c (group combined mean)
7. Baseline age (combined group mean)
8. Baseline BMI (combined group mean)
9. Baseline IGT percentage (%)
10. Hazard ratio
11. Number of cases in each group and number of patients who progressed to type 2 diabetes mellitus
Risk of bias:
Assessed with the Cochrane risk of bias (RoB) Tool.
Statistical analysis: Meta-regression
Statistical analysis software: SAS 9.4 or higher
| 2024 | Year | 10 | Month | 20 | Day |
| 2024 | Year | 10 | Month | 20 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063871